Citations

Clear

4 citation(s) found for "Smith, Barbara".

A Microsphere-Based Sensor for Point-of-Care and Non-Invasive Acetone Detection
Pérez, Óscar Osorio , Nguyen, Ngan Anh, Denham, Landon , Hendricks, Asher, Domínguez, R. , Jeong, Eun Ju , Carvalho, Márcio S. , Lima, Mateus, Eshima, Jarrett , Yu, Nanxi , Smith, Barbara S. , Wang, Shaopeng , Kulick, Doina , Forzani, Erica , Dominguez, Rodrigo E , Smith, Barbara , Wang, Shaopeng , Perez, Oscar Osorio, Jeong, Eun Ju, Lima, Mateus

Mayo Clinic

Biosensors | July 3, 2025 | Volume: 15 | Issue: 7 | Pages: 429

10.3390/bios15070429 | PMID 40710079 Get It

Ketones, which are key biomarkers of fat oxidation, are relevant for metabolic health maintenance and disease development, making continuous monitoring essential. In this study, we introduce a novel colorimetric sensor designed for potential continuous acetone detection in biological fluids. The sensor features a polydimethylsiloxane (PDMS) shell that encapsulates a sensitive and specific liquid-core acetone-sensing probe. The microsphere sensors were characterized by evaluating their size, PDMS shell thickness, colorimetric response, and sensitivity under realistic conditions, including 100% relative humidity (RH) and CO2 interference. The microsphere size and sensor sensitivity can be controlled by modifying the fabrication parameters. Critically, the sensor showed high selectivity for acetone detection, with negligible interference from CO2 concentrations up to 4%. In addition, the sensor displayed good reproducibility (CV < 5%) and stability under realistic storage conditions (over two weeks at 4 °C). Finally, the accuracy of the microsphere sensor was validated against a gold standard gas chromatography-mass spectrometry (GC-MS) method using simulated and real breath samples from healthy individuals and type 1 diabetes patients. The correlation between the microsphere sensor and GC-MS produced a linear fit with a slope of 0.948 and an adjusted R-squared value of 0.954. Therefore, the liquid-core microsphere-based sensor is a promising platform for acetone body fluid analysis.
A systematic review and gap analysis of frailty and oral health characteristics in older adults: A call for clinical translation
Slashcheva, Lyubov , Karjalahti, Erika, Hassett, Leslie C. , Smith, Barbara J. , Slashcheva, Lyubov D , Hassett, Leslie C , Smith, Barbara, Chamberlain, Alanna M.

Mayo Clinic

Gerodontology | July 31, 2021 | Volume: 38 | Issue: 4 | Pages: 338-350

10.1111/ger.12577 | PMID 34331353 Get It

AbstractObjectiveThis systematic review updates the evidence for association between oral health characteristics and frailty status, identifying gaps in translational dental research and application of frailty assessment into clinical practice.BackgroundClinicians have little guidance on stage‐appropriate dental treatment for medically complex older adults. Oral health characteristics have been associated with frailty status, determined through validated assessment tools representing a concise measure of health. Translation of frailty assessment into dental practice has not been the focus of previous reviews.MethodsUtilising the PRISMA framework for systematic reviews, a comprehensive database search identified articles describing the association of interest. Those included were cross‐sectional or longitudinal, in English, included participants aged 50 years or older, used validated frailty assessments and measured clinically relevant oral health outcomes. From 835 screened articles, 26 full‐text articles were eligible for quality appraisal and synthesis.ResultsFrailty prevalence ranged from 8.5% to 66.0%. Most studies utilised the Fried frailty criteria. Qualitative synthesis of 17 cross‐sectional and nine longitudinal studies demonstrated significant covariate‐adjusted association between frailty status and number of teeth, chewing ability, prosthetic characteristics, dental caries, periodontitis, dental utilisation and oral health‐related quality of life factors. Variability in findings reflected study sample diversity based on country of study origin, age at recruitment, sample size, frailty assessment type, use of clinical versus self‐reported outcome measures and differences in statistical analysis.ConclusionDespite robust evidence of association with oral health characteristics, frailty assessment has yet to be sufficiently applied to translational dental research and clinical practice.
Statement of the Science Concerning Locoregional Treatments After Preoperative Chemotherapy for Breast Cancer: A National Cancer Institute Conference
Harris, Jay R., Pockaj, Barbara A. , Khouri, Nagi F., Hylton, Nola, Whelan, Timothy J. , Pierce, Lori J. , Esserman, Laura J. , Newman, Lisa A. , Smith, Barbara L. , Mamounas, Eleftherios P. , Buchholz, Thomas A. , Lehman, Constance Dobbins , Miller, Michael J. , Bear, Harry D. , Mamounas, Eleftherios P. , Esserman, Laura J , Whelan, Timothy J

Mayo Clinic

Journal of Clinical Oncology | February 7, 2008 | Volume: 26 | Issue: 5 | Pages: 791-797

10.1200/jco.2007.15.0326 | PMID 18258988 Get It

Purpose To review the state of the science with respect to diagnostic imaging and locoregional therapy for patients with breast cancer receiving preoperative chemotherapy. Methods Published data relevant to clinical staging, monitoring of tumor response, and locoregional therapy for patients with breast cancer treated with preoperative chemotherapy were reviewed. Results High-quality data from prospective randomized trials are limited. Available data suggest that locoregional therapy decisions should be based on both the pretreatment clinical extent of disease and the pathologic extent of the disease after chemotherapy. Accordingly, physical examination and imaging studies that accurately define the initial extent of disease are required before treatment. Sentinel lymph node biopsy can be performed either before or after preoperative chemotherapy for patients with clinical N0 disease. The success of breast conservation after preoperative chemotherapy depends on careful patient selection and achieving negative surgical margins. Adjuvant breast radiation is indicated for all patients treated with breast conservation. For patients treated with mastectomy, chest-wall and regional nodal radiation should be considered for those who present with clinical stage III disease or have histologically positive lymph nodes after preoperative chemotherapy. Additional prospective studies are needed to determine the value of postmastectomy radiation for patients with stage II breast cancer who have negative lymph nodes after chemotherapy. Conclusion The increased use of preoperative chemotherapy has raised new questions concerning the optimal methods to stage and monitor disease response to treatment and how to optimize locoregional treatment. The available evidence suggests that a multidisciplinary approach improves outcomes.